For emergency use: WHO approves AstraZeneca vaccine from India and South Korea

"We now have all the pieces in place to rapidly distribute vaccines. But we still need to increase production," said WHO director-general Tedros Adanom Gebrejesus.

4472 views 3 comment(s)
Illustration, Photo: Shutterstock
Illustration, Photo: Shutterstock
Disclaimer: The translations are mostly done through AI translator and might not be 100% accurate.

Today, the World Health Organization (WHO) approved the vaccine against the coronavirus manufactured by AstraZeneca (AstraZeneca) produced in Asian countries.

The WHO announcement states that the vaccine produced by AstraZeneka-SKBio (from South Korea) and Serum Institute from India has been approved, reports Reuters.

This procedure paves the way for the distribution of hundreds of millions of doses to vulnerable countries that have not yet received a vaccine against the coronavirus, WHO officials told journalists today.

"Now we have all the pieces available for the rapid distribution of vaccines. But we still need to increase production," said WHO director-general Tedros Adanom Gebrejesus.

The approval applies to two versions of the AstraZeneca vaccine manufactured in India and South Korea.

With this approval, countries that do not have the means to independently determine efficacy and safety are expected to have faster access to the vaccine.

The vaccine was approved days after a WHO panel provided interim recommendations, saying adults must be given two doses about eight to 12 weeks apart and can also be used in countries with the South African variant.

Bonus video: